These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1611652)

  • 1. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
    Iravani A; Doyle CA; Durham SJ; Wilber RB
    Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
    Christenson JC; Gooch WM; Herrod JN; Swenson E
    J Antimicrob Chemother; 1991 Oct; 28(4):581-6. PubMed ID: 1761453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
    Parish LC; Doyle CA; Durham SJ; Wilber RB
    Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
    McCarty JM
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
    Iravani A
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1940-2. PubMed ID: 1952874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
    McCarty JM; Renteria A
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.
    Christenson JC; Swenson E; Gooch WM; Herrod JN
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1127-30. PubMed ID: 1929253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP; Nemeth MA; Keyserling CH; Hotary LH; Tack KJ
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
    Iravani A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):750-2. PubMed ID: 2069382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefaclor into the millennium.
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1999 Jun; 11(3):163-78. PubMed ID: 10435677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefprozil, a new cephalosporin: its use in various clinical trials.
    Gainer RB
    South Med J; 1995 Mar; 88(3):338-46. PubMed ID: 7886533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
    Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
    Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.